Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

20/05/2022 EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 20/05/2022 Position Statement on Exercise Dosage in Rheumatic and Musculoskeletal Diseases: The Role of the IMPACT-RMD Toolkit 17/05/2022 EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology 10/11/2021 Implementing the 27 PRISMA 2020 Statement items for systematic reviews in the sport and exercise medicine, musculoskeletal rehabilitation and sports science fields: the PERSiST (implementing Prisma in Exercise, Rehabilitation, Sport medicine and SporTs science) guidance 19/02/2021 EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs) 11/01/2018 Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements 30/09/2013 Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries 13/08/2013 ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis 09/08/2013 Research reporting standards for percutaneous vertebral augmentation 15/07/2013 Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

Blog archives

Latest guest blogger